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Abstract 
Background: Longitudinal associations between triglycerides (TG) and other metabolic 
syndrome (MetS) components have rarely been reported. The purpose was to investigate the 
longitudinal association between TG and other MetS components with time. 
Methods: The longitudinal study was established in 2007 on individuals who attended health 
check-ups at Beijing Tongren Hospital and Beijing Xiaotangshan Hospital. Data used in this study 
was based on 7489 participants who had at least three health check-ups over a period of 5-year 
follow up. Joint model was used to explore longitudinal associations between TG and other MetS 
components after adjusted for age. 
Results: There were positive correlations between TG and other MetS components except for 
high density lipoprotein (HDL), and the correlations increased with time. A negative correlation 
was displayed between TG and HDL, and the correlation also increased with time. Among all five 
pairs of TG and other MetS components, the marginal correlation between TG and body mass 
index (BMI) was the largest for both men and women. The marginal correlation between TG and 
fasting plasma glucose was the smallest for men, while the marginal correlation between TG and 
diastolic blood pressure was the smallest for women. 
Conclusions: The longitudinal association between TG and other MetS components increased 
with time. Among five pairs of TG and other MetS components, the longitudinal correlation 
between TG and BMI was the largest. It is important to closely monitor subjects with high levels of 
TG and BMI in health check-up population especially for women, because these two components 
are closely associated with development of hypertension, diabetes, cardiovascular disease and 
other metabolic diseases. 
Key words: Triglycerides, Metabolic syndrome components, Longitudinal correlation, Joint model 
Introduction 
Metabolic syndrome (MetS) refers to a group of 
inter-related risk factors that include hyperglycemia, 
elevated blood pressure (BP), elevated triglycerides 
(TG), low high-density lipoprotein (HDL) levels, and 
obesity (in particular, central obesity) [1]. MetS is a 
strong predictor of cardiovascular disease (CVD), 
diabetes, stroke, and all-cause mortality, and is 
becoming a major public-health challenge worldwide 
[2-6]. Although, it is not yet clear whether MetS has a 
single cause, it is acknowledged that the most critical 
pathophysiology is insulin resistance [7, 8], and 
therefore the importance of central obesity was 
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established [9]. 
Hypertriglyceridemia is often observed in 
subjects with MetS, type 2 diabetes, stroke, or 
combined with hyperlipidemia [10, 11]. The level of 
TG is an independent risk factor for CVD events, 
independent of serum HDL or low-density 
lipoprotein (LDL) levels [12]. A number of 
meta-analyses have been published demonstrating 
associations between TG levels and CVD risk, 
independent of HDL level [13, 14]. 
There are several cross-sectional studies 
regarding the association between TG and other MetS 
components. In a cross sectional survey study on 266 
Turkish elderly aged people, TG was reported to be 
significantly correlated with weight, body mass index 
(BMI), waist circumference (WC), waist/hip and 
waist/height [15]. In another study involving healthy 
Japanese women, high level of TG was also associated 
with increased level of BMI [16]. Other two studies 
have also recognized positive correlation between TG 
and other metabolic risk factors using partial 
correlation analysis and pearson correlation analysis 
[17, 18]. However, there have been limited data about 
longitudinal associations between TG and other MetS 
components. To fully understand the longitudinal 
association between TG and other MetS components, 
longitudinal studies are required, especially using 
repeated measures of MetS components. 
Therefore, the aim of the present study was to 
assess longitudinal associations between TG and 
other MetS components in a Beijing adult population 
from 2007 to 2012. 
Methods 
Participants 
The longitudinal study was set up in 2007 on 
adults who attended health check-ups at Beijing 
Tongren Hospital and Beijing Xiaotangshan Hospital. 
A total of 7489 subjects with at least three health 
check-ups in the 5-year follow-up were enrolled in the 
study. Individuals with a previous diagnosis of CVD, 
cerebral infarction, gastric cancer, or those who had 
undergone coronary artery bypass surgery, coronary 
stenting surgery or gastrectomy, or those who had 
MetS, obesity, dyslipidemia, hyperglycemia, or 
hypertension at baseline were excluded. The study 
was approved by the ethics committee of Capital 
Medical University of China, and performed in 
accordance with the principles of Declaration of 
Helsinki (2013SY26). All participants gave their 
informed written consents. 
Definition of MetS 
MetS was diagnosed if participants had three or 
more of the following risk determinants according to 
the Joint Interim Statement criteria [1]. However, WC 
was not measured because of limited health check-up 
site, and BMI was taken as a substitute for the 
component of obesity [19]. The determinants were as 
follows: 
• Obesity: BMI ≥ 28 kg/m²; 
• Elevated TG (drug treatment for elevated TG is 
an alternate indicator) ≥ 150 mg/dL (1.7 
mmol/L);  
• Reduced HDL (drug treatment for reduced HDL 
is an alternate indicator) < 40 mg/dL (1.0 
mmol/L) in males, < 50 mg/dL (1.3 mmol/L) in 
females;  
• Elevated BP (antihypertensive drug treatment in 
a patient with a history of hypertension is an 
alternate indicator) systolic blood pressure (SBP) 
≥ 130 mmHg and/or diastolic blood pressure 
(DBP) ≥ 85 mmHg;  
• Elevated fasting plasma glucose (FPG) (drug 
treatment of elevated glucose is an alternate 
indicator) ≥ 100 mg/dL. 
Measurements 
The participants underwent routine physical 
examinations that included the measurement of 
height, weight, BP, and overnight fasting blood 
sampling. Weight and height were measured without 
shoes, and BMI was calculated as weight (kg) divided 
by squared height (m). The measurement of weight 
was undergone at least twice for the improvement of 
reliability. The intra variability of weight was < 5%. 
BP was measured on the right upper arm and 
maintained at the level of the heart with participants 
in sitting position. BP was measured by trained and 
certified nurses working in Beijing Tongren Hospital 
and Beijing Xiaotangshan Hospital. Before measuring 
BP, subjects were at rest for at least 5 minutes. The 
trained nurse will measure BP three times in the 
following 30 minutes. During the 30 min preceding 
the measurements, the subjects were required to 
refrain from smoking or consuming caffeine. A 
standard mercury sphygmomanometer was used 
with 1 of 4 cuff sizes (pediatric, regular adult, large 
adult, or thigh) based on the participant’s arm 
circumference. Three readings of SBP and DBP were 
recorded, and the average of the last two 
measurements was used for data analysis. 
Blood samples were obtained from antecubital 
vein into tubes containing ethylenediaminetetraacetic 
acid (EDTA) in the morning after an overnight fasting 
period. Then the samples were stored in 4°C 
refrigerator, and they will be analyzed in 8 hours. 
HDL, TG, and FPG were measured by enzymatic 
method using a chemistry analyzer (Beckman LX 20, 
America) at Department of Clinical Laboratory in 
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Beijing Tongren Hospital and Beijing Xiaotangshan 
Hospital. All analyses performed in accordance with 
the manufacturer's recommendations. 
Statistical Analysis 
Missing Data Imputation and Data analysis 
To account for missing values, multiple 
imputation (MI) was performed. Because the 
imputation method of choice depended on the pattern 
of missing data and the type of the imputed variables, 
the Markov Chain Monte Carlo method was chosen to 
avoid loss of generality. The MI procedure of SAS 
software package (version 9.2; SAS Institute, Chicago, 
IL, USA) was used [20]. 
Data were expressed as mean ± standard 
deviation or, for non-normally distributed variables, 
as median and interquartile range. To compare the 
differences between groups, student’s t test or 
Wilcoxon rank sum test was used to determine 
differences between groups. Joint model was 
conducted using SAS mixed procedure to account for 
longitudinal correlations between TG and other MetS 
components. Data were analyzed using SAS software 
package and P < 0.05 was considered as significant.  
When there were two continuous response 
variables, Y1 and Y2, they were measured over time 
for a number of subjects. Each of the variables was 
described using the linear mixed-effects model: 
Y1i(t)=µ1(t)+a1i+b1it+ε1i(t) 
Y2i(t)=µ2(t)+a2i+b2it+ε2i(t) 
The marginal correlation between Y1 and Y2 at 
time t is given by: 
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Table 1. Basic characteristics and MetS components of subjects in 
2007 and 2012 
Year Variables Men Women t P 
2007 N 3389 4100 – – 
 age 41.55±10.81 41.03±10.24 -2.13 0.0332 
 BMI (kg/m2) 23.42±2.50 21.80±2.53 -27.88 <0.0001 
 FPG (mmol/L) 4.88±0.42 4.86±0.40 -2.12 0.0341 
 HDL (mmol/L) 1.35±0.27 1.63±0.30 43.27 <0.0001 
 SBP (mmHg) 111.25±9.11 105.94±10.43 -23.49 <0.0001 
 DBP (mmHg) 73.72±6.58 69.87±7.42 -23.76 <0.0001 
 TG (mmol/L) 1.04±0.35 0.85±0.34 -24.62 <0.0001 
2012 N 1744 2171 – – 
 BMI (kg/m2) 24.26±2.70 22.45±2.81 -20.36 <0.0001 
 FPG (mmol/L) 5.16±0.53 5.05±0.45 -6.94 <0.0001 
 HDL (mmol/L) 1.27±0.28 1.57±0.33 30.61 <0.0001 
 SBP (mmHg) 119.58±13.32 113.24±14.33 -14.31 <0.0001 
 DBP (mmHg) 73.03±9.80 69.56±9.71 -11.08 <0.0001 
 TG (mmol/L) 1.33±0.74 1.04±0.53 -14.06 <0.0001 
Abbreviations: MetS = metabolic syndrome; BMI = body mass index; FPG = fasting 
plasma glucose; HDL= high-density lipoprotein; SBP = systolic blood pressure; DBP = 
diastolic blood pressure; TG = triglycerides. 
–: Test was not performed on sample size (n). 
Table 2. Fixed-Effects Tests of age for all subjects 
Pairs of MetS components Outcome Men Women 
t# p# t# p# 
TG and BMI TG  7.73 <0.0001 20.79 <0.0001 
 BMI  7.62 <0.0001 24.28 <0.0001 
TG and FPG TG  7.30 <0.0001 20.70 <0.0001 
 FPG  6.40 <0.0001  3.93 <0.0001 
TG and HDL TG  8.46 <0.0001 22.17 <0.0001 
 HDL  1.89  0.0582 -2.72  0.0066 
TG and SBP TG  7.43 <0.0001 17.07 <0.0001 
 SBP 11.55 <0.0001 24.20 <0.0001 
TG and DBP DBP 13.80 <0.0001 21.46 <0.0001 
 TG  7.23 <0.0001 20.73 <0.0001 
Abbreviations: MetS = metabolic syndrome; BMI = body mass index; FPG = fasting 
plasma glucose; HDL= high-density lipoprotein; SBP = systolic blood pressure; DBP = 
diastolic blood pressure; TG = triglycerides. 
#: Joint Model was used. 
 
Results 
Basic characteristics and MetS components of 
the subjects 
The basic characteristics and MetS components 
of the study population in 2007 and 2012 were shown 
in Table 1. There were 7489 individuals included in 
the study in 2007 at baseline (3389 men, 41.55±10.81 
years; 4100 women, 41.03±10.24 years). Significant 
differences were displayed in the levels of age, BMI, 
FPG, HDL, SBP, DBP, and TG between men and 
women. 
Results of Joint Model 
Fixed-effects tests for age are displayed in Table 
2. It was indicated that age had significant effects on 
the development of TG, BMI, FPG, SBP and DBP for 
men. And age had significant effects on the 
development of all MetS components for women. 
The marginal correlations between TG and other 
MetS components after adjusted for age are presented 
in Table 3, Figure 1 and Figure 2. 
Longitudinal correlations between TG and other 
MetS components for men adjusted for age were 
presented in Figure 1. There were positive 
correlations between TG and other MetS components 
except for HDL, and the correlations gradually 
increased with time. A negative correlation was 
displayed between TG and HDL, and the correlation 
also increased with time. Among all five pairs of TG 
and other MetS components, the marginal correlation 
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between TG and BMI was the largest, and the 
marginal correlation between TG and FPG was the 
smallest. 
Longitudinal correlations between TG and other 
MetS components for women adjusted for age were 
displayed in Figure 2. Positive associations were 
detected between TG and other MetS components 
except for HDL, and the correlations increased 
rapidly with time. TG was negatively correlated with 
HDL, and the correlation also increased with time. 
Among all the five cases, the marginal correlation 
between TG and BMI was the largest, and the 
marginal correlation between TG and DBP was the 
smallest. 
 
 
Table 3. The marginal correlation between TG and other MetS 
components for all subjects 
 Pairs of MetS 
components 
2007 2008 2009 2010 2011 2012 
Men TG and BMI* 0.2423 0.2433 0.2571 0.2792 0.3060 0.3350 
 TG and FPG* 0.0654 0.0649 0.0777 0.0980 0.1213 0.1450 
 TG and HDL* -0.1583 -0.1682 -0.1891 -0.2173 -0.2500 -0.2848 
 TG and SBP* 0.0830 0.0973 0.1170 0.1391 0.1616 0.1832 
 TG and DBP* 0.0959 0.1092 0.1282 0.1495 0.1710 0.1915 
Women TG and BMI* 0.2140 0.3919 0.4793 0.5235 0.5479 0.5624 
 TG and FPG* 0.0696 0.1518 0.1967 0.2201 0.2331 0.2409 
 TG and HDL* -0.1708 -0.3429 -0.4312 -0.4765 -0.5016 -0.5166 
 TG and SBP* 0.0927 0.2218 0.3000 0.3426 0.3668 0.3814 
 TG and DBP* 0.0818 0.0909 0.1051 0.1227 0.1421 0.1621 
Abbreviations: MetS = metabolic syndrome; BMI = body mass index; FPG = fasting 
plasma glucose; HDL= high-density lipoprotein; SBP = systolic blood pressure; DBP = 
diastolic blood pressure; TG = triglycerides. 
*: P<0.001 
 
 
 
 
 
Figure 1. The marginal correlations between TG and other MetS 
components for men. Abbreviations: BMI = body mass index; FPG = fasting 
plasma glucose; HDL= high-density lipoprotein; SBP = systolic blood 
pressure; DBP = diastolic blood pressure; TG = triglycerides; MetS = 
metabolic syndrome. 
 
Figure 2. The marginal correlations between TG and other MetS 
components for women. Abbreviations: BMI = body mass index; FPG = 
fasting plasma glucose; HDL= high-density lipoprotein; SBP = systolic blood 
pressure; DBP = diastolic blood pressure; TG = triglycerides; MetS = 
metabolic syndrome. 
 
Discussion 
Longitudinal associations between TG and other 
MetS components over time have rarely been 
considered in previous studies. Joint model is a novel 
method detecting longitudinal association between 
two outcomes. 
Joint modeling two MetS components, rather 
than modeling them independently, and therefore 
incorporates additional information into the model 
that may increase estimation and prediction accuracy. 
Joint model has often been applied for longitudinal 
measurements and time-to-event data [21, 22]. The 
model also has been used for two longitudinal 
continuous measurements. One previous study using 
the joint model detected a very strong association 
between the development of two hearing thresholds 
and a slowly increasing change in the association 
between these thresholds over time [23]. However, 
there are few inferences about using the joint model to 
analyze the longitudinal association between TG and 
other MetS components with time. 
In the present study, longitudinal associations 
between TG and other MetS components were 
assessed after adjusted for age. It was suggested that 
the marginal correlation between TG and BMI was the 
largest and the correlation increased with time for 
both men and women. And the correlation between 
TG and BMI is larger for women than men. The 
positive association was also reported in previous 
literature using partial correlation analysis in a cross 
sectional study [17]. But no inference has shown the 
longitudinal association between TG and BMI. 
Positive association between TG and BMI was also 
Int. J. Med. Sci. 2016, Vol. 13 
 
http://www.medsci.org 
449 
detected in the present study, as shown previously 
[19, 24]. Therefore, it is important to closely monitor 
subjects with high levels of TG and BMI especially for 
women, because these two components are closely 
associated with development of hypertension, 
diabetes, CVD and other chronic diseases. 
The marginal correlation between TG and FPG 
was positive and increased with time for men and 
women. But the correlation between TG and FPG is 
larger for women than men. Previous literatures have 
suggested that individuals with elevated FPG usually 
have a number of other metabolic abnormalities, 
including elevated TG, and elevated BP [24-26]. It has 
been reported that lipotoxicity by deposition of TG 
may be associated with beta-cell dysfunction and 
insulin resistance [27].  
The marginal correlation between TG and HDL 
increased with time for both genders. The correlation 
between TG and HDL was extremely larger for men 
than women. The strong association between TG and 
HDL were consistent with previous results [25, 28, 
29]. One study has shown that an increase in TG level 
is commonly associated with a reduction in HDL level 
[30]. It has been indicated that hypertriglyceridemia 
stimulates the enzymatic activity of cholesterol ester 
transfer protein, which facilitates the transfer of TG 
from TG-rich lipoproteins to HDL and LDL in 
exchange for cholesteryl esters [31]. This leads to an 
increase in TG content of HDL and LDL. 
The marginal correlation between TG and BP 
increased slowly with time for men and women in the 
present study. The correlation between TG and SBP 
was a little larger for women than men. But the 
correlation between TG and DBP for men was slightly 
larger for men than women. One previous study has 
shown a significant increase in plasma TG level as BP 
levels increased from optimally normal, across 
high-normal to hypertensive levels [32]. 
The strength of this research was that it was a 
longitudinal study of 5 years in a Beijing adult 
population. The present study assessed longitudinal 
association between TG and other MetS components 
for the first time. The limitation was the lack of WC as 
an indicator for central obesity, however, BMI was 
used for substitute. One study showed that the two 
measures of BMI and WC are closely correlated [33]. 
Another study indicated that most individuals with 
an abnormal BMI also have an abnormal WC. Both 
indexes of excess adiposity are positively associated 
with SBP, FPG, and TG and inversely associated with 
HDL [34]. One study based on a cross-sectional field 
survey targeted adults in China demonstrated that 
dyslipidemia, particularly hypertriglyceridemia and 
low HDL is associated with central obesity (measured 
with WC) using multivariate logistic regression [35]. 
A previous study used both BMI and WC has shown 
that either of the two measures can be recommended 
in screening for MetS in routine clinical practice in 
order to combat CVD and type 2 diabetes [36]. In 
addition, this study was based on an adult population 
of health check-up. This limits the generalizability of 
the data to other populations to some extent. Further 
studies using the general population would be 
desirable. 
Conclusions 
The present study assessed longitudinal 
association between TG and other MetS components 
for the first time. The longitudinal association 
between TG and other MetS components increased 
with time. Among five pairs of TG and other MetS 
components, the correlation between TG and BMI was 
the largest. The correlation between TG and FPG was 
the smallest for men, while the correlation between 
TG and DBP was the smallest for women. It is 
important to closely monitor subjects with high levels 
of TG and BMI in health check-up population 
especially for women, because these two components 
are closely associated with development of 
hypertension, diabetes, CVD, and other chronic 
diseases. 
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